Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FFL7V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,675
Award facts
- Contract value 100% obligated
- $19,675.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,675.19 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, for the supply of TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units). This firm fixed-price delivery order is not set aside and is scheduled for completion by January 30, 2026. The award was executed under AmerisourceBergen's parent company Cencora, Inc.'s existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 31, 2031), which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, competitively won this order to fulfill federal medical procurement needs for military and veteran healthcare systems. The TRELEGY ELLIPTA product is a combination inhaler used for respiratory disease management, consistent with AmerisourceBergen's broader federal portfolio of specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The rapid completion timeline reflects the urgent nature of pharmaceutical supply deliveries typically managed through DLA's medical supply chain operations supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FFL7V?
SPE2DR26FFL7V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FFL7V worth?
The government has obligated $19,675 on SPE2DR26FFL7V.
Is contract SPE2DR26FFL7V an order under another contract?
Yes. SPE2DR26FFL7V is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL7V competed?
The extent of competition for SPE2DR26FFL7V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award